Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial
- PMID: 40823083
- PMCID: PMC12355047
- DOI: 10.3389/fonc.2025.1658958
Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial
Abstract
[This corrects the article DOI: 10.3389/fonc.2025.1561692.].
Keywords: metformin; neoadjuvant; remission; survival analysis; triple negative breast neoplasm.
Copyright © 2025 Ramani, Sadashivaiah and Naik.
Erratum for
-
Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.Front Oncol. 2025 Jun 25;15:1561692. doi: 10.3389/fonc.2025.1561692. eCollection 2025. Front Oncol. 2025. PMID: 40636683 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources